4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-020638
CEO and Chairman sold 16,680 shares at an average $22.50 ($375,236)
- CEO and Chairman acquired 16,680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-03-19 | Exercise or conversion : show line 1 in the form | +11,120 | $0.33 | $3,670 | 1,889,300 | D |
| 2020-03-19 | Sale : show line 2 in the form | −11,120 | $22.30 | $247,976 | 1,878,180 | D |
| 2020-03-20 | Exercise or conversion : show line 3 in the form | +5,560 | $0.33 | $1,835 | 1,883,740 | D |
| 2020-03-20 | Sale : show line 4 in the form | −3,700 | $22.37 | $82,769 | 1,880,040 | D |
| 2020-03-20 | Sale : show line 5 in the form | −973 | $23.50 | $22,866 | 1,879,067 | D |
| 2020-03-20 | Sale : show line 6 in the form | −887 | $24.38 | $21,625 | 1,878,180 | D |
| Open-market sales · 16,680 sh · avg $22.50 · $375,236 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-03-19 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −11,120 | 702,160 | D |
| 2020-03-20 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −5,560 | 696,600 | D |
Loading xslF345X03/doc4.xml…